TENOSYNOVIAL GIANT CELL TUMOR, DIFFUSE

Clinical trials for TENOSYNOVIAL GIANT CELL TUMOR, DIFFUSE explained in plain language.

Never miss a new study

Get alerted when new TENOSYNOVIAL GIANT CELL TUMOR, DIFFUSE trials appear

Sign up with your email to follow new studies for TENOSYNOVIAL GIANT CELL TUMOR, DIFFUSE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet recruiting 1 Not yet finished but already full! 2

Could a Pre-Surgery drug slash recurrence in rare joint tumors?

Disease control Not yet recruiting

This trial investigates whether taking pimicotinib—a drug that blocks a protein driving tumor growth—for 12 weeks before surgery can improve outcomes for people with diffuse tenosynovial giant cell tumor (D-TGCT), a rare but aggressive joint tumor with a high recurrence rate. Par…

Matched conditions: TENOSYNOVIAL GIANT CELL TUMOR, DIFFUSE

Phase: PHASE2 • Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University • Aim: Disease control

Last updated Jul 18, 2026 00:00 UTC

TENOSYNOVIAL GIANT CELL TUMOR, DIFFUSE

Get alerted when new TENOSYNOVIAL GIANT CELL TUMOR, DIFFUSE trials appear

Could a Pre-Surgery drug slash recurrence in rare joint tumors?